These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 33585558)

  • 1. Characteristics of COVID-19 Patients Based on the Results of Nucleic Acid and Specific Antibodies and the Clinical Relevance of Antibody Levels.
    Chen H; Qin R; Huang Z; He L; Luo W; Zheng P; Huang H; Wang H; Sun B
    Front Mol Biosci; 2020; 7():605862. PubMed ID: 33585558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
    Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
    Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program.
    Wendel S; Kutner JM; Machado R; Fontão-Wendel R; Bub C; Fachini R; Yokoyama A; Candelaria G; Sakashita A; Achkar R; Hamerschlak N; Scuracchio P; Amaral M; Dal Ben M; Araujo D; Soares C; Camargo A; Kallás E; Durigon E; Reis LF; Rizzo LV
    Transfusion; 2020 Dec; 60(12):2938-2951. PubMed ID: 32935877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of combined detection of SARS-CoV-2-specific antibody and nucleic acid.
    Meng QB; Peng JJ; Wei X; Yang JY; Li PC; Qu ZW; Xiong YF; Wu GJ; Hu ZM; Yu JC; Su W
    World J Clin Cases; 2020 Oct; 8(19):4360-4369. PubMed ID: 33083395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value analysis of IgM and IgG antibodies detected by nucleic acid in patients with COVID-19.
    Ding T; Zhang N
    Am J Transl Res; 2021; 13(6):7089-7103. PubMed ID: 34306469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.
    Chen J; Niu Z; Li H; Tang D; Zhang P
    Arch Iran Med; 2021 May; 24(5):427-433. PubMed ID: 34196209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers.
    Xiao T; Wang Y; Yuan J; Ye H; Wei L; Liao X; Wang H; Qian S; Wang Z; Liu L; Zhang Z
    Front Med (Lausanne); 2021; 8():595773. PubMed ID: 33791320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid and antibody assay results in Chinese patients with coronavirus disease 2019 (COVID-19).
    Lu Y; Li Y; Wang Y; Luo J; Yu W
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107089. PubMed ID: 33068863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection methods and dynamic characteristics of specific antibodies in patients with COVID-19: A review of the early literature.
    Xu J; Chen J; Wen F; Liu K; Chen Y
    Heliyon; 2024 Feb; 10(3):e24580. PubMed ID: 38317938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases.
    Zeng H; Deng S; Zhou Z; Qiu X; Jia X; Li Z; Wang J; Duan H; Tu L; Wang J
    Public Health; 2020 Sep; 186():1-5. PubMed ID: 32731151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance verification of anti-SARS-CoV-2-specific antibody detection by using four chemiluminescence immunoassay systems.
    Wan Y; Li Z; Wang K; Li T; Liao P
    Ann Clin Biochem; 2020 Nov; 57(6):429-434. PubMed ID: 32961061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.
    Nicholson S; Karapanagiotidis T; Khvorov A; Douros C; Mordant F; Bond K; Druce J; Williamson DA; Purcell D; Lewin SR; Sullivan S; Subbarao K; Catton M
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab239. PubMed ID: 34258311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum virus-specific IgM/IgG antibody in asymptomatic and discharged patients with reoccurring positive COVID-19 nucleic acid test (RPNAT).
    Liu J; Lian R; Zhang G; Hou B; Wang C; Dong J; Yang L; Wang J; Dai S; Chen L; Zhang G; Lu X; Ye T
    Ann Med; 2021 Dec; 53(1):34-42. PubMed ID: 32808808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of SARS-CoV-2 nasopharyngeal swab PCR positivity in COVID-19 convalescent plasma donors.
    Ikegami S; Benirschke R; Flanagan T; Tanna N; Klein T; Elue R; Debosz P; Mallek J; Wright G; Guariglia P; Kang J; Gniadek TJ
    Transfusion; 2020 Dec; 60(12):2962-2968. PubMed ID: 32840002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
    Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
    Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.